Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Indian Journal of Forensic Medicine & Toxicology
Rakesh Kumar Sehgal1 , R.L. Koul2
Unknown Affiliation
Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Whither to Public Interest-The Curious Case of Compulsory Drug Licensing in Indian Pharmaceutical Industry Rakesh Kumar Sehgal1 , R.L. Koul2
Indian Journal of Forensic Medicine & Toxicology Vol. 14 No. 4 (2020): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v14i4.13202

Abstract

Countries like India which are grappling with providing healthcare to heterogeneous and varied base ofstakeholders including those at the bottom of pyramid have their own share of availability and affordabilityconcerns in the healthcare sector for providing access of life saving drugs to the vast segment of Indianpopulation and move towards the achievement of the Sustainable Developmental Goals (SDGs); in processaddressing not only adequate availability of the primary health care but achieving the competition frameworkvis- a- vis patent control as the Original Patents which intend to protect innovation tangentially run across theconsequential price determination power by monopolistic patented drug companies. Compulsory licensing ofPatents provisions are used by the Governments as a means to correct anti-competitive practices to promotepublic interest or public health and in cases of emergency avoiding monopolies at the hands of patent holdersto deter anti-competitive violations by engaging in unfair competition or abuse of dominant position in themarket which aspect is so crucial to provide outreach of cheaper and quality drugs in common good.
Co-Authors